AdvaMed and Georgia Bio Send Letter to Natural Resources & Environment Committee Related to Ethylene Oxide

On behalf of the Advanced Medical Technology Association (AdvaMed) and Georgia Bio, we wrote to the Natural Resources & Environment Committee to share our comments on Senate Bill 426, being considered by the legislature, related to ethylene oxide. As you may know, billions of medical devices each year in the U.S. are sterilized using ethylene oxide. The direct impact of severe restriction on the ability to sterilize medical devices could compromise the medical device industry’s ability to provide a consistent, stable, and safe supply of medical supplies to patients nationwide during the COVID-19 pandemic.

As the threat of antimicrobial resistance to disease-causing, mutating microbes continues to rise in the U.S. and around the globe, now more than ever, we need to ensure the medical and surgical equipment health care providers use is sterile. Ethylene oxide allows sterile surgeries to happen.

Please click here to view the full letter to the committee.

May 13, 2026
Georgia Life Sciences thanks Dr. Marty Makary for his service as Commissioner of the U.S. Food and Drug Administration during a period of significant change across the nation’s health and regulatory agencies.
May 12, 2026
Georgia Life Sciences is pleased to announce Tim Opler as a featured keynote speaker at the 2026 Georgia Life Sciences Summit, taking place August 25-26 at the Sandy Springs Performing Arts Center in Atlanta. A leading voice in biotech investment banking, Tim Opler serves as Managing Director in Stifel’s Global Healthcare Group, where he advises innovative life sciences companies on financing, growth strategy, and market positioning across the healthcare landscape. Tim brings deep insight into the evolving biotech investment environment, emerging industry trends, and the factors shaping the future of life sciences innovation and commercialization. Join us for this timely discussion with one of the industry’s most respected financial leaders as we explore the opportunities and challenges defining the next era of life sciences growth . 
May 5, 2026
New coalition forms to develop a national innovation roadmap to strengthen and extend  America’s global leadership in biotechnology
MORE POSTS